New conditioning regimen with idarubicin and melphalan in autologous PBPC transplantation

被引：0
|
作者：
Musso, M
Porretto, F
Crescimanno, A
Bondi, F
Polizzi, V
Scalone, R
Cajozzo, A
Mariani, G
机构：
[1] Univ Palermo, Cattedra Ematol TMO, I-90133 Palermo, Italy
[2] Univ Palermo, Div Ematol TMO, I-90133 Palermo, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
342
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION
    MARIT, G
    CONY, P
    DAVID, B
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 78 - 78
  • [32] Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen
    Hagen, Patrick
    D'Souza, Anita
    Hari, Parameswaran
    Davila, Omar
    Zhang, Mei-Jie
    Vesole, David H.
    Smith, Scott E.
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    BLOOD, 2019, 134
  • [33] BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    ALEGRE, A
    LAMANA, M
    ARRANZ, R
    FERNANDEZVILLALTA, MJ
    TOMAS, JF
    FIGUERA, A
    CAMARA, R
    STEEGMAN, JL
    CASADO, F
    REQUENA, MJ
    PLANAS, JL
    VAZQUEZ, L
    GRANDA, A
    FERNANDEZRANADA, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 380 - 386
  • [34] Mitoxantrone and melphalan conditioning regimen for autologous peripheral blood stem cell transplantation in adults with acute myelogenous leukemia.
    Sprague, K
    Padgaonkar, V
    Klein, AK
    Chan, GW
    Miller, KB
    Klingemann, H
    BLOOD, 2005, 106 (11) : 466B - 466B
  • [35] INTRAVENOUS BUSULPHAN IN COMBINATION WITH ETOPOSIDE AND MELPHALAN USED AS CONDITIONING REGIMEN FOR AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN LYMPHOMAS: EVALUATION OF TOXICITY
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Papalexandri, A.
    Penopoulos, V.
    Sakellari, I.
    Anagnostopoulos, A.
    Fassas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 449 - 450
  • [36] Selinexor in Combination with Standard or Reduced-Dose Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma
    Shuai, Su
    Xu, Bin
    Li, Chunrui
    Wang, Di
    Tong, Xiwen
    Zhu, Yi
    Mao, Xia
    Xiao, Min
    Zhang, Donghua
    BLOOD, 2024, 144 : 7062 - 7063
  • [37] Autologous bone marrow transplantation for acute myeloid leukaemia in children using total body irradiation and melphalan as conditioning regimen
    Bonetti, F
    Locatelli, F
    Pession, A
    Messina, C
    Giorgiani, G
    Zecca, M
    Santoro, N
    Porta, F
    Favre, C
    Montagna, D
    BLOOD, 1995, 86 (10) : 356 - 356
  • [38] Melphalan and total-body irradiation as a conditioning regimen for autologous bone marrow transplantation in acute myeloid leukemia.
    Treleaven, J
    Powles, R
    Singhal, S
    Horton, C
    Tait, D
    Meller, S
    Pinkerton, CR
    Mehta, J
    BLOOD, 1995, 86 (10) : 3861 - 3861
  • [39] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [40] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
12345